- Home
- SBS vs ICLR Comparison
SBS vs ICLR Comparison
Compare SBS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBS | ICLR |
|---|---|---|
| Founded | 1954 | 1990 |
| Country | Brazil | Ireland |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4B | 14.3B |
| IPO Year | 2002 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SBS | ICLR |
|---|---|---|
| Price | $25.12 | $185.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $201.23 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 11-10-2025 | 10-22-2025 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.98 | ★ 7.47 |
| Revenue | $6,502,517,346.00 | ★ $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.38 | $0.76 |
| P/E Ratio | ★ $12.82 | $24.87 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.87 | $125.10 |
| 52 Week High | $27.25 | $228.29 |
Technical Indicators
Market Signals| Indicator | SBS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 62.18 |
| Support Level | $26.53 | $174.13 |
| Resistance Level | $27.08 | $191.15 |
| Average True Range (ATR) | 0.60 | 8.46 |
| MACD | -0.09 | 2.87 |
| Stochastic Oscillator | 4.96 | 85.77 |
Price Performance
Historical ComparisonAbout SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.